- Question from PEN: Do doctors typically prescribe Tykerb at the same time as Herceptin, or is this the wave of the future?
- Answers - Kathy D. Miller, M.D. It is potentially the wave of the future. The combination of Herceptin and Tykerb (chemical name: lapatinib) has been studied in one trial in ladies with metastatic disease, and in that study the combination was more effective than Tykerb alone. That study was in women with very advanced metastatic disease and did not include chemotherapy. That study helped support the ongoing ALTTO trial, which includes the combination of Herceptin and Tykerb with chemotherapy as one of the treatment options for women with early-stage disease.
The Ask-the-Expert Online Conference called Updates From the 2009 San Antonio Breast Cancer Symposium featured Kathy Miller, M.D. and Kristin Brill, M.D., F.A.C.S. answering your questions about the latest updates on breast cancer risk, screening techniques, treatment options, and more.
Editor's Note: This conference took place in December 2009.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.